US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 8.480
  • +0.040+0.47%
Close Dec 13 16:00 ET
  • 8.380
  • -0.100-1.18%
Post 19:54 ET
452.63MMarket Cap-3.98P/E (TTM)

About Zevra Therapeutics Company

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Company Profile

SymbolZVRA
Company NameZevra Therapeutics
Listing DateApr 16, 2015
Founded2006
CEOMr. Neil F. McFarlane, M.S.
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address1180 Celebration Boulevard,Suite 103
CityCelebration
ProvinceFlorida
CountryUnited States of America
Zip Code34747
Phone1-321-939-3416
Websitehttp://zevra.com

Company Executives

  • Name
  • Position
  • Salary
  • Neil F. McFarlane, M.S.
  • Director, President and Chief Executive Officer
  • 3.45M
  • Dr. Adrian Quartel, M.D.
  • Chief Medical Officer
  • --
  • R. LaDuane Clifton, C.P.A.,M.B.A.
  • Chief Financial Officer, Secretary and Treasurer
  • 2.26M
  • Joshua Schafer, M.B.A.
  • Chief Commercial Officer and Executive Vice President, Business Development
  • 1.82M
  • Dr. Sven Guenther, PhD
  • Chief Scientific Officer
  • --
  • Timothy J. Sangiovanni
  • Senior Vice President, Corporate Controller and Principal Accounting Officer
  • --
  • Tamara A. Favorito
  • Chairman of the Board
  • 324.39K
  • Dr. Alvin Shih, M.D.
  • Director
  • --
  • Douglas W. Calder
  • Independent Director
  • 258.02K
  • John B. Bode
  • Independent Director
  • 264.31K
  • Thomas Anderson
  • Independent Director
  • 243.04K
  • Corey Watton
  • Independent Director
  • 260.67K
  • Dr. Wendy L. Dixon, PhD
  • Independent Director
  • 274.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List